Peripheral Vascular Disease and Carotid Artery Disease Are Associated with Decreased Bile Acid Excretion

Low bile acid excretion (BAE) is associated with a higher risk of coronary artery disease (CAD) and cerebrovascular disease (stroke). This study investigated BAE in patients with peripheral vascular disease (PVD) and carotid artery disease (CA) and those without these diseases, compared to patients with CAD, stroke, or no evidence of atherosclerosis. Patients with complaints of chest pain-suspected CAD, syncope, stroke/TIA, severe headache, intermittent claudication, or falls were enrolled. All received a 4-day standard diet with 490 mg of cholesterol and internal standard copper thiocyanate. Fecal BAE was measured using gas–liquid chromatography. One hundred and three patients, sixty-eight (66%) men and thirty-five women (34%), mean age range 60.9 ± 8.9 years, were enrolled in this prospective, 22-year follow-up study. Regression analysis showed that advanced age, total BAE, and excretion of the main fractions were the only significant independent factors that predicted prolonged survival (p < 0.001). Twenty-two years’ follow-up revealed only 15% of those with BAE <262.4 mg/24 h survived, compared to >60% of participants without atherosclerosis and a mean BAE of 676 mg/24 h. BAE was lower in patients with polyvascular atherosclerosis than in those with involvement of 1–3 vascular beds. Pearson correlations were found between total BAE and various fractions of BA, as well as HDL cholesterol. BAE and short-term survival were decreased among patients with PVD compared to those with CAD or stroke. Low BAE should be considered a valuable and independent risk factor for PVD.

[1]  H. Sokol,et al.  Circulating bile acids concentration is predictive of coronary artery disease in human , 2021, Scientific Reports.

[2]  I. Novikov,et al.  Reduced bile acid excretion is an independent risk factor for stroke and mortality: A prospective follow-up study. , 2019, Atherosclerosis.

[3]  Manesh R Patel,et al.  Polyvascular Disease: Reappraisal of the Current Clinical Landscape. , 2019, Circulation. Cardiovascular interventions.

[4]  L. Wechsler Statins and Stroke - It's Complicated. , 2019, The New England journal of medicine.

[5]  O. Rogowski,et al.  Diminished bile acids excretion is a risk factor for coronary artery disease: 20-year follow up and long-term outcome , 2017, Therapeutic advances in gastroenterology.

[6]  S. Kliewer,et al.  Bile Acids as Hormones: The FXR-FGF15/19 Pathway , 2015, Digestive Diseases.

[7]  Michael C. McDaniel,et al.  Coronary angiographic scoring systems: an evaluation of their equivalence and validity. , 2012, American heart journal.

[8]  V. Meiner,et al.  On the mechanism of accumulation of cholestanol in the brain of mice with a disruption of sterol 27-hydroxylase , 2010, Journal of Lipid Research.

[9]  J. Chiang,et al.  Bile acids: regulation of synthesis , 2009, Journal of Lipid Research.

[10]  J. Auwerx,et al.  [Cholesterol metabolism modulators in future drug therapy for atherosclerosis]. , 2005, Medecine sciences : M/S.

[11]  Y. Yamori,et al.  FISH and LIFESTYLE‐RELATED DISEASE PREVENTION: EXPERIMENTAL AND EPIDEMIOLOGICAL EVIDENCE FOR ANTI‐ATHEROGENIC POTENTIAL OF TAURINE , 2004, Clinical and experimental pharmacology & physiology.

[12]  Guorong Xu,et al.  Inhibition of ileal bile acid transport lowers plasma cholesterol levels by inactivating hepatic farnesoid X receptor and stimulating cholesterol 7 alpha-hydroxylase. , 2004, Metabolism: clinical and experimental.

[13]  R. van Haperen,et al.  Increased Fecal Bile Acid Excretion in Transgenic Mice With Elevated Expression of Human Phospholipid Transfer Protein , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[14]  K. Eagle,et al.  Missed Opportunities to Treat Atherosclerosis in Patients Undergoing Peripheral Vascular Interventions: Insights From the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2) , 2002, Circulation.

[15]  H. Gylling,et al.  Cholesterol Absorption, Synthesis, and Fecal Output in Postmenopausal Women With and Without Coronary Artery Disease , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[16]  H. Gylling,et al.  Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. , 2000, Journal of the American College of Cardiology.

[17]  S. Grundy,et al.  Effects of continuous and intermittent feeding on biliary lipid outputs in man: application for measurements of intestinal absorption of cholesterol and bile acids. , 1979, Journal of lipid research.

[18]  T. Gilat,et al.  Quantitative analysis of single stool samples using a continuous marker , 1972, The American Journal of Digestive Diseases.

[19]  S. Grundy,et al.  QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL FECAL BILE ACIDS. , 1965, Journal of lipid research.

[20]  P. Rabinovich,et al.  [Clinical value of the cholesterol test in patients with arteriosclerosis]. , 1987, Kardiologiia.